| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Sep―14 |
Risk Factors of Bleedings in Patients with COVID-19 Receiving Anticoagulants for Venous Thromboembolism Prevention |
A.B. Agapov, R.E. Kalinin, N.D. Mzhavanadze, V.O. Povarov, A.A. Nikiforov, D.A. Maksayev, et al. (+2) A.A. Chobanyan, I.A. Suchkov |
| 2 |
[GO] |
2024―Jun―17 |
Efficacy and Safety of a New Selective Oral Factor Xa Inhibitor Amidine Hydrochloride for Prevention of Thromboembolic Events in Hospitalized Patients with COVID-19: a Multiple-Center Prospective Randomized Controlled Study |
I.A. Suchkov, N.D. Mzhavanadze, A.A. Shuldyakov, Z.G. Tatarintseva, N.V. Kirichenko, D.A. Sychev, et al. (+6) L.K. Brizhan, O.E. Balashov, A.A. Chobanian, D.A. Maksaev, N.Yu. Pshenichnaya, N.V. Lomakin |
| 3 |
[GO] |
2022―May―17 |
Venous Thromboembolism in COVID-19 Patients During the First and the Second Waves of the Pandemic: Real-Practice Data |
R.E. Kalinin, I.A. Suchkov, V.B. Filimonov, N.D. Mzhavanadze, A.B. Agapov, A.S. Golovchenko |
|
